Evidence map›Paper›PMID 31312028›Full record

ArticleMucosal immunology2019

A pro-inflammatory CD8+ T-cell subset patrols the cervicovaginal tract.

Laura Pattacini, Amanda Woodward Davis, Julie Czartoski, Florian Mair, Scott Presnell, Sean M Hughes, Ollivier Hyrien, Gretchen M Lentz, Anna C Kirby, Michael F Fialkow and 3 more

Abstract read
In one paragraph

Article in Mucosal immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. T-Cell Biology in the Female Reproductive Tract: Relevance to HIV Infection.American journal of reproductive immunology (New York, N.Y. : 1989) · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Observational
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Interactions between microbiota and cervical epithelial, immune, and mucus barrier.Frontiers in cellular and infection microbiology · 2023
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Laura PattaciniVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Amanda Woodward DavisVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Julie CzartoskiVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Florian MairVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Scott PresnellSystem Immunology Division, Benaroya Research Institute, Seattle, WA, USA.
Sean M HughesDepartments of Obstetrics and Gynecology, and Medicine, University of Washington, Seattle, WA, USA.
Ollivier HyrienVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Gretchen M LentzDepartments of Obstetrics and Gynecology, and Medicine, University of Washington, Seattle, WA, USA.
Anna C KirbyDepartments of Obstetrics and Gynecology, and Medicine, University of Washington, Seattle, WA, USA.
Michael F FialkowDepartments of Obstetrics and Gynecology, and Medicine, University of Washington, Seattle, WA, USA.
Florian HladikDepartments of Obstetrics and Gynecology, and Medicine, University of Washington, Seattle, WA, USA.
Martin PrlicVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Jennifer M LundVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. jlund@fredhutch.org.

Funding

Immunoprotective Properties of Tissue-resident Memory T Cells in Mice and Humans within Mucosal SitesR01AI121129 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI LUND, JENNIFER M, PRLIC, MARTIN · 2016 to 2022
$5.0M
Identification of Novel Mucosal Immune Mechanisms Involved in Protection from HIV-1R01AI131914 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI LINGAPPA, JAIRAM RAO, LUND, JENNIFER M · 2017 to 2021
$4.0M
Systems and carcinogenic impact assessment of topical microbicides on human mucosaR01AI116292 · NIAID · UNIVERSITY OF WASHINGTON · PI HLADIK, FLORIAN · 2015 to 2019
$3.5M
Extracellular vesicles in semen and genital HIV infection and immunity during heroin addiction and methadone or buprenorphine substitution therapyR01DA040386 · NIDA · UNIVERSITY OF WASHINGTON · PI HLADIK, FLORIAN · 2015 to 2019
$2.6M
Quantifying the impact of genital mucosal inflammation on HIV-1 acquisition riskR01AI111738 · NIAID · UNIVERSITY OF WASHINGTON · PI LINGAPPA, JAIRAM RAO · 2014 to 2017
$2.3M
Effects of HIV infection on resident memory T cellsR21AI125025 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI PATTACINI, LAURA · 2016 to 2017
$484k
NIAID NIH HHS R01 AI111738NIAID NIH HHS R01 AI116292NIAID NIH HHS R01 AI121129NIAID NIH HHS R01 AI131914NIAID NIH HHS R21 AI125025NIDA NIH HHS R01 DA040386
6 · The paper itself

Abstract

The immune system of the cervicovaginal tract (CVT) must balance immunosurveillance and active immunity against pathogens with maintenance of tolerance to resident microbiota and to fetal and partner antigens for reproductive purposes. Thus, we predicted that CVT immunity is characterized by distinctive features compared to blood and other tissue compartments. Indeed, we found that CVT CD8+ T-cells had unique transcriptional profiles, particularly in their cytokine signature, compared to that reported for CD8+ T-cells in other tissue sites. Among these CVT CD8+ T-cells, we identified a CD69- CD103- subset that was characterized by reduced migration in response to tissue-exit signals and higher pro-inflammatory potential as compared to their blood counterpart. These inflammatory mucosal CD8+ T-cells (Tim) were increased in frequency in the CVT of individuals with chronic infection, pointing to a potential role in perpetuating inflammation. Our findings highlight the specialized nature of immunity within the CVT and identify Tim cells as potential therapeutic targets to tame tissue inflammation upon chronic infection.

Indexed as

AdultAnimalsAntigens, CDAntigens, Differentiation, T-LymphocyteBiomarkersCD69 AntigensCD8-Positive T-LymphocytesCervix UteriCytokinesFemaleGene Expression ProfilingHumansImmunologic MemoryImmunophenotypingInflammation MediatorsIntegrin alpha Chainsalpha E integrinsAntigens, CDAntigens, Differentiation, T-LymphocyteBiomarkersCD69 AntigensCytokinesInflammation MediatorsIntegrin alpha ChainsLectins, C-Type

Identifiers

PMID31312028
PMCPMC6717561

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.